CompletedPhase 4

Optimal Dosage of Remifentanil for Vertebroplasty

Taiwan80 participantsStarted 2023-05-20

Plain-language summary

Percutaneous vertebroplasty has become a mainstay in the management of osteoporotic and malignant vertebral fractures. Procedural analgesia and sedation (PAS) with propofol and remifentanil may provides optimal hypnotic and analgesic effects.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anesthesiologists (ASA) score of I-III patients receiving percutaneous vertebroplasty under procedural sedation and analgesia with remifentanil and propofol Exclusion Criteria: * Age \< 20 or \> 80 years * ASA classifications \> III * Pregnancy * Known allergies to opioids, propofol or any drugs used in the study * Emergency surgery * Patient refusal

What they're measuring

Adequate analgesia at the time of the trocar needle insertion

Timeframe: Time at the trocar needle placement

Adequate analgesia at the time of the bone cement injection

Timeframe: Time at the bone cement injection

Trial details

NCT IDNCT05876039

SponsorTri-Service General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-24

View on ClinicalTrials.gov More Remifentanil trials